TY - JOUR
AU - Cunningham, Steve
AU - Mpamhanga, Chengetai d
AU - Swann, Olivia V
AU - Drysdale, Simon B
AU - Liu, Xinxue
AU - Groves, Helen
AU - O'Hagan, Shaun
AU - Waterfield, Thomas
AU - Iskander, Dalia
AU - Lyttle, Mark d
AU - Marlow, Robin
AU - Maxwell-Hodkinson, Abigail
AU - Sinha, Ian P.
AU - Roland, Damian
AU - Williams, Thomas C.
PY - 2024
DA - December
TI - Update to: Study Pre-protocol for "BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study"
JO - Wellcome Open Research
VL - 6
DO - https://doi.org/10.12688/wellcomeopenres.16778.4
AB - BACKGROUND: In 2021 we launched the BronchStart study, which collected information on 17,899 presentations in children with serious respiratory tract infections following the release of lockdown restrictions. Our study informed the Joint Committee on Vaccination and Immunisation's decision to recommend the introduction maternal respiratory syncytial virus (RSV) vaccination, which was introduced in the United Kingdom in August/September 2024.
PB - F1000 Research
UR - https://www.research.ed.ac.uk/en/publications/635284da-bf6d-4b18-98be-95f9e3d819a3
KW - Coronavirus (COVID-19)
ER